LL-37 5mg (CAP-18)

Description

Description

LL-37 5mg (CAP-18) is a human cathelicidin-derived research peptide widely studied for its roles in host defense, immune modulation, and tissue repair. Sourced from superior quality raw materials and synthesized using cutting-edge technology, our LL-37 ensures top-notch purity and efficacy for detailed and rigorous research initiatives.

Key Features:

• Produced in compliance with the strictest industry standards for purity and consistency.

• Each batch undergoes stringent quality checks to ensure uniform reliability.

• Supplied in a lyophilized format to maintain stability and efficacy under recommended storage conditions.

Applications:

• Investigating antimicrobial mechanisms against diverse pathogens.

• Exploring biofilm disruption and synergy with conventional antimicrobials.

• Examining roles in wound healing, inflammation control, and immune modulation.

Specifications and Documentation

• Material Safety Data Sheet (MSDS): Coming Soon.

• Handling and Storage Instructions: Coming Soon.

LL-37 5mg (CAP-18) is highly regarded in the research sector for its prospective applications in antimicrobial, immunology, and wound-healing studies, offering researchers a valuable tool for profound exploration of these topics.